%PDF-1.4
%
179 0 obj
<>
endobj
176 0 obj
<>
endobj
243 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2003-07-09T11:18:07Z
2024-03-28T03:44:55-07:00
QuarkXPressª 4.11: AdobePS 8.8.0 (301)
2024-03-28T03:44:55-07:00
application/pdf
Heather
2002-630.aug
uuid:e5c7810f-1dd1-11b2-0a00-8908275d6100
uuid:e5c78113-1dd1-11b2-0a00-aa0000000000
endstream
endobj
163 0 obj
<>
endobj
165 0 obj
<>
endobj
164 0 obj
<>
endobj
166 0 obj
<>
endobj
118 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 155 0 R/Type/Page>>
endobj
121 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 157 0 R/Type/Page>>
endobj
249 0 obj
[253 0 R]
endobj
250 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.03 612 -792 re
W n
BT
0 0 0 1 k
/GS1 gs
/T1_0 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 74.4 714.5293 Tm
[(induced by nitric oxide. )54.8 (Am J Pathol 1995;146:75-85.)]TJ
-2.175 -1.25 Td
[(44.)-875.1 (Cao L, )36.8 (Y)99.8 (ang BB. Chondrocyte apoptosis induced by aggrecan G1)]TJ
2.175 -1.25 Td
(domain as a result of decreased cell adhesion. Exp Cell Res)Tj
0 Tc 0 Tw 0 -1.25 TD
(1999;246:527-37.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(45.)-875.1 (Salvucci O, Mami-Chouaib F)79.7 (, Moreau JL, )17.7 (Theze J, Chehimi J,)]TJ
2.175 -1.25 Td
[(Chouaib S. Dif)17.7 (ferential regulation of interleukin-12- and inter-)]TJ
T*
(leukin-15-induced natural killer cell activation by interleukin-4. Eur)Tj
T*
(Immunol 1996;26:2736-41.)Tj
-2.175 -1.25 Td
[(46.)-875.1 (Cesano )54.8 (A, )17.7 (V)59.8 (isonneau S, Clark SC, Santoli D. Cellular and )]TJ
2.175 -1.25 Td
(molecular mechanisms of activation of MHC nonrestricted )Tj
T*
(cytotoxic cells by IL-12. J Immunol 1993;151:2943-57.)Tj
30.825 12.5 Td
[(47.)-875.1 (McInnes IB, al-Mughales J, Field M, et al. )17.7 (The role of )]TJ
2.175 -1.25 Td
[(interleukin-15 in )17.7 (T)91.9 (-cell migration and activation in rheumatoid)]TJ
T*
(arthritis. Nat Med 1996;2:175-82.)Tj
-2.175 -1.25 Td
[(48.)-875.1 (Ribbens C, )54.8 (Andre B, Kaye O, et al. Increased synovial fluid levels)]TJ
2.175 -1.25 Td
(of interleukin-12, sCD25 and sTNF-RII/sTNF-RI ratio delineate a)Tj
T*
(cytokine pattern characteristic of immune arthropathies. Eur)Tj
T*
[(Cytokine Netw 2000;1)36.8 (1:669-76.)]TJ
ET
0 0 0 1 K
54 54 m
558 54 l
S
BT
/T1_1 1 Tf
8 0 0 8 424.3613 35.9844 Tm
(The Journal of Rheumatology 2003; 30:8)Tj
0 Tc 0 Tw -46.2952 -0.0313 Td
(1810)Tj
ET
0 0 0 0 k
/GS0 gs
109.25 59.1 396.47 -10.84 re
f*
0.5 w
109.25 59.1 396.47 -10.84 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 0 0 rg
/GS2 gs
/T1_2 8 Tf
117.48 51 Td
(Personal, non-commercial use only. The Journal of Rheumatology Copyrig\
ht \251 2003. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_3 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
157 0 obj
<>stream
8;Z\s#nDSA$j?P/&,JAA`)e*6LHn!ZUF;cp=kall"o'rCAK':b+JUO@6SZ!6[877n
OZp^H/EAp.05ESi"$M&p1>f%g@>jS58bOHubL^[-X%QR`%SC_"Ck(_m<*!=d3GRs2
X%_!sC:TsjQ<-q$?#/:.hr27dqYpToHVuLL*bY/Ie+a#O=M%MS>lR:Zzz!!"A,31#G;
-skH[Z/'IIIF
endstream
endobj
161 0 obj
[/Indexed/DeviceRGB 255 160 0 R]
endobj
160 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
187 0 obj
<>
endobj
182 0 obj
<>
endobj
218 0 obj
<>
endobj
248 0 obj
<>
endobj
183 0 obj
<>
endobj
210 0 obj
<>stream
H{PSw冀y]pK}n}hQW (!G!